Dear Sir, Please find Re-lodgment request report received from RTA of the company for the months of October and November 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Omkar Pharmachem Ltd has submitted to BSE the bi-monthly report from its Registrar and Transfer Agent (Alankit Assignments Ltd) on physical share transfer re-lodgment requests, as required under the SEBI circular dated July 2, 2025. The report covers October 2025 and November 2025. For both months, the RTA reported zero requests received, zero processed, zero approved, and zero rejected. This indicates that no shareholders sought to re-lodge any physical share transfer requests during this period.
This is a routine procedural compliance filing with no impact on shareholders or the stock price. It simply confirms that no physical share transfer re-lodgment requests were received during the reported period.